APPLICATIONS FOR WOMEN’S HEALTH
From addressing common issues of joint degeneration to managing surgical wounds, ulcerations to thinning of the vaginal wall and urinary incontinence due to a breakdown of connective tissue of the pelvic floor, women’s health encompasses a wide spectrum of needs.
Contact UsWomen have unique health care requirements that demand attention and understanding.
While intricacies of the female body reveal fascinating facts, these insights underscore the importance of tailored healthcare approaches to meet the specific needs of women.
THE ROLE OF REGENERATIVE MEDICINE IN SEXUAL WELLNESS
Over time, a person’s private regions may undergo changes that negatively influence their daily life and significantly impact relationships. If the interest and excitement in the bedroom diminishes, it might be advisable to explore treatments aimed at reversing a decline in libido and the satisfaction of orgasms. Fortunately, innovative technologies like connective tissue supplementation can aid the body in regenerating itself, bringing vitality back to one’s sexual experiences.
“I think patients would be surprised that healthcare providers are open to having the discussion. You could talk to your family care physician. You could talk to your urologist. You could talk to a cosmetic physician. But I think if you can overcome that hurdle of talking to your physician or healthcare provider, I think you would be surprised how helpful they could be.”
-Dr. Welch, Board-Certified Dermatologist
By consulting a healthcare professional, you will receive personalized advice, exams and discuss evidence-backed treatments if needed. Avoid self-prescribing or trying unverified methods. Rely on reputable sources and healthcare professionals for more information on connective tissue supplementation that may provide better function with no time restrictions.
The connective tissue supplementation procedure is minimally invasive, with virtually no downtime. People can undergo it and swiftly resume their regular activities. Despite its simplicity, this procedure can genuinely impact one’s situation, providing an opportunity for a better lifestyle and more satisfying experiences.
Regenerative Medicine in Orthopedic Applications
What is CryoText?
CryoText™ is our most concentrated, non-coded Wharton’s jelly or human umbilical cord product that is rich in cytokines, growth factors, and scaffolding proteins. It is used as a replacement tissue intended to replace missing or damaged connective tissue.
Advantages of Cryotext
CryoText™ is used as replacement tissue that is inserted or implanted into the joint or injured area. CryoText™ does not use any material obtained directly from the embryo or fetus. CryoText™ has higher concentrations of peptides, hyaluronic acid and growth factors when compared to amniotic fluid suspensions. CryoText™ is processed from human tissue, donated following full term, c-section deliveries, in accordance with the FDA.
Regenative Labs’ resources are divided into the following categories:
Discover
Discover our catalogue of applications and methods showcasing how Regenative Labs’ proprietary products can be used. Our proven methods are used by physicians in the forefront of regenerative medicine to replace or supplement missing or damaged tissue to restore mobility and functionality to improve patients’ lives. From proverbial head-to-toe, learn how this valuable resource can help.
View all ApplicationsSTUDY
Study the detailed descriptions of our effective and versatile products, their make-up and development through our state-of-the-art process and to identify which products are best suited for your patients’ unique needs. For a personalized approach and response, please contact us at [insert link to form].
VIEW ALL PRODUCTSEXPLORE
Explore the latest innovations and the variety of options available to medical specialties.
View PublicationsCommitment to Quality and Transparency
Regenative Labs is a leader in the field of regenerative medicine. Our commitment to quality and transparency is demonstrated by collecting data from patient outcomes and analyzing it for statistical significance, ensuring physicians make the most informed decision to facilitate the best possible outcomes for their patients.
From our retrospective data repository, you will witness improvements beginning at the 30-day mark.
Improving Quality of Life
When we experience pain, our body sends a message that something is wrong. Pain is merely a symptom of an underlying condition or injury. Using steroids or opiates alone to address pain caused by injury is akin to putting a picture over a hole in the wall instead of repairing the hole.
With connective tissue supplementation, medical providers have an opportunity to address the problem at its source by inserting new, viable connective tissue ECM directly to the site of the breakdown, or defect (via syringe). The patient’s body can use the collagenic superstructure from the newly transplanted Wharton’s jelly as building blocks to fill voids or defects in cartilage beds or other soft tissues.
LEARN About Wharton’s Jelly
About Wharton’s Jelly
Advances in regenerative medicine have increased significantly throughout the past decade. Wharton’s Jelly (WJ) was initially characterized in 1656 by Thomas Wharton[1]. Since its initial discovery, there has been significant interest in the use of WJ in regenerative medicine applications[2]. Located between the blood vessels of the umbilical cord and the amniotic epithelium, WJ spans the entire length of the umbilical cord, providing protection, cushioning, and structural support [2,3]. Initial research centered on WJ as a cellular product, dependent on the metabolic activity of living cells to exert its primary function[3]. However, current research demonstrates that WJ exerts an effect independent of any cellular activity[3]. Initially classified as a mucoid connective tissue, we now know that WJ functions as an ideal system to transplant chemokine and growth factors, in addition to providing a biomechanical microarchitecture for collagen extracellular matrix formation in collagen-based defects[4].
CITATIONS:
1. Kim DW, Staples M, Shinozuka K, Pantcheva P, Kang SD, Borlongan CV. Wharton’s jellyderived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci. 2013 May 31;14(6):11692-712. doi: 10.3390/ijms140611692. PMID: 23727936; PMCID: PMC3709752.
2. Gupta A, El-Amin SF 3rd, Levy HJ, Sze-Tu R, Ibim SE, Maffulli N. Umbilical cordderived Wharton’s jelly for regenerative medicine applications. J Orthop Surg Res. 2020 Feb 13;15(1):49. doi: 10.1186/s13018-020-1553-7. PMID: 32054483; PMCID: PMC7017504.
3. Deus IA, Mano JF, Custódio CA. Perinatal tissues and cells in tissue engineering and regenerative medicine. Acta Biomater. 2020 Jul 1;110:1-14. doi: 10.1016/j. actbio.2020.04.035. Epub 2020 May 14. PMID: 32418650.
4. Jadalannagari S, Converse G, McFall C, Buse E, Filla M, Villar MT, Artigues A, MellotAJ, Wang J, Detamore MS, Hopkins RA, Aljitawi OS. Decellularized Wharton’s Jelly from human umbilical cord as a novel 3D scaffolding material for tissue engineering applications. PLoS One. 2017 Feb 21;12(2):e0172098. doi: 10.1371/journal. pone.0172098. Erratum in: PLoS One. 2017 Mar 7;12 (3):e0173827. PMID: 28222169; PMCID: PMC5319682.
Advantages of Wharton’s Jelly
This connective tissue contains high amounts of extracellular matrix components including collagen types I, III, and V, elastin, and fibronectin that provide a natural scaffold to facilitate cellular adhesion [1, 2]. Wharton’s jelly mainly provides cushioning and structural support to the umbilical cord but also contains a natural source of long-chain hyaluronic acid and numerous cytokines and growth factors. Studies have described placental tissues to be “immune privileged” as they rarely evoke an immune response in the body, reducing the risk of adverse reactions [3].
CITATIONS:
1. Kim DW, Staples M, Shinozuka K, Pantcheva P, Kang SD, Borlongan CV. Wharton’s jellyderived mesenchymal stem cells: phenotypic characterization and optimizing their therapeutic potential for clinical applications. Int J Mol Sci. 2013 May 31;14(6):11692-712. doi: 10.3390/ijms140611692. PMID: 23727936; PMCID: PMC3709752.
2. Gupta A, El-Amin SF 3rd, Levy HJ, Sze-Tu R, Ibim SE, Maffulli N. Umbilical cordderived Wharton’s jelly for regenerative medicine applications. J Orthop Surg Res. 2020 Feb 13;15(1):49. doi: 10.1186/s13018-020-1553-7. PMID: 32054483; PMCID: PMC7017504.
3. Jadalannagari S, Converse G, McFall C, Buse E, Filla M, Villar MT, Artigues A, MellotAJ, Wang J, Detamore MS, Hopkins RA, Aljitawi OS. Decellularized Wharton’s Jelly from human umbilical cord as a novel 3D scaffolding material for tissue engineering applications. PLoS One. 2017 Feb 21;12(2):e0172098. doi: 10.1371/journal. pone.0172098. Erratum in: PLoS One. 2017 Mar 7;12 (3):e0173827. PMID: 28222169; PMCID: PMC5319682.
CryoText™ Product Information
For more information about our Cryotext product, visit the link below.
Pricing and PLACING AN order
For pricing or to place an order, login or setup an account to get immediate access to our MEDNGINE platform.
DON’t HESITATE TO REACH OUT.
If you have any further questions, please contact us. We look forward to speaking with you!